Status:
COMPLETED
Malaria Transmission and Immunity in Highland Kenya
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
Plasmodium Falciparum Malaria
Eligibility:
All Genders
Up to 99 years
Brief Summary
The purpose of this study is to see why malaria epidemics occur in highland areas in Kenya. A better understanding of factors contributing to malaria may be necessary for malaria vaccine planning. The...
Detailed Description
The purpose of this study is to see why malaria epidemics occur in highland areas in Kenya. A better understanding of factors contributing to malaria may be necessary for malaria vaccine planning. The...
Eligibility Criteria
Inclusion
- Active surveillance of clinical malaria -Individuals of any age who live in the area (Kipsamoite or Kapsisiywa) for more than 6 months of the year, or, if they are new to the area, who plan to live in the area for more than 6 months of the year (permanent residents).
- Passive surveillance of clinical malaria
- Any individual living within the boundaries of the 2 study areas (Kipsamoite and Kapsisiywa)
Exclusion
- Active surveillance of clinical malaria
- Declining to participate in the study
- Will be gone from site more than 1 week per month
- Not available for weekly symptom check or bimonthly blood sample collection
- Passive surveillance of clinical malaria
- Declining to participate in the study
- Participation in active surveillance study
Key Trial Info
Start Date :
October 1 2006
Trial Type :
OBSERVATIONAL
End Date :
January 31 2011
Estimated Enrollment :
20610 Patients enrolled
Trial Details
Trial ID
NCT00393757
Start Date
October 1 2006
End Date
January 31 2011
Last Update
February 1 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kenya Medical Research Institute
Kisumu, Kenya, 40100